JAK2 and essential thrombocythemia: Patients with positive CALR mutation significantly involved a younger age population (ET, p = 0.025; PMF, p = 0.002) and their platelet counts were higher than JAK2 mutation-positive subjects (ET, p < 0.001; PMF, p = 0.001).